ethyl (2Z)-2-chloro-2-[2-(4-ethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

Tyrphostin AG 490>98.0%(HPLC)(T)100mg

(4-Bromo-2-fluorophenyl)acetic acid methyl ester, 98.0%, 25g

4-Bromo-1H-indole-6-carbonitrile, 95.0%, 1g

Methyl pyrrolidine-2-carboxylate hydrochloride, 95.0%, 25g

3,5-Bis(trifluoromethyl)-N-ethylaniline, 97.0%, 5g

methyl 2-hydroxy-4-(3-methylphenyl)-4-oxobut-2-enoate, 95%, 500mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole, 95.0%, 1g

(R)-4-BROMO-2-[[(TERT-BUTOXY)CARBONYL]AMINO]BUTANOIC ACID TERT-BUTYL ESTER, 95.0%, 1g

3-Bromo-5-methyl-1,2,4-oxadiazole, 95.0%, 5g

Sodium pivalate, 95.0%, 250mg

tert-Butyl 4-aminobenzylcarbamate hydrochloride, 95.0%, 250mg

Valerensäure, mit analyt. Unterlagen, 100 mg, Glasverpackung